Submission Details
| 510(k) Number | K122110 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 17, 2012 |
| Decision Date | November 21, 2012 |
| Days to Decision | 127 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K122110 is an FDA 510(k) clearance for the ACON ON CALL VIVID PAL BLOOD GLUCOSE MONITORING SYSTEM, a Glucose Oxidase, Glucose (Class II — Special Controls, product code CGA), submitted by ACON Laboratories, Inc. (San Diego, US). The FDA issued a Cleared decision on November 21, 2012, 127 days after receiving the submission on July 17, 2012. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K122110 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 17, 2012 |
| Decision Date | November 21, 2012 |
| Days to Decision | 127 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | CGA — Glucose Oxidase, Glucose |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |